Oral Immunotherapy Using Probiotic Ice Cream Containing Recombinant Food-Grade Lactococcus lactis Which Inhibited Allergic Responses in a BALB/c Mouse Model

This study was conducted to evaluate the effects of recombinant probiotic bacteria as a candidate for oral vaccine with the potential of treating allergy to Amaranthus retroflexus pollens. The main gene of this allergen, Ama r 2, was cloned into the food grade plasmid pNZ7025 and then was electrotra...

Full description

Saved in:
Bibliographic Details
Main Authors: Alireza Vasiee, Fereshteh Falah, Mojtaba Sankian, Farideh Tabatabaei-Yazdi, Seyed Ali Mortazavi
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2020/2635230
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832567295398903808
author Alireza Vasiee
Fereshteh Falah
Mojtaba Sankian
Farideh Tabatabaei-Yazdi
Seyed Ali Mortazavi
author_facet Alireza Vasiee
Fereshteh Falah
Mojtaba Sankian
Farideh Tabatabaei-Yazdi
Seyed Ali Mortazavi
author_sort Alireza Vasiee
collection DOAJ
description This study was conducted to evaluate the effects of recombinant probiotic bacteria as a candidate for oral vaccine with the potential of treating allergy to Amaranthus retroflexus pollens. The main gene of this allergen, Ama r 2, was cloned into the food grade plasmid pNZ7025 and then was electrotransformed into the food grade Lactococcus lactis NZ1330. No expression was observed in the primary structure due to the distance between the ribosome binding site and the start codon. Therefore, the vector structure was corrected using the site-directed mutagenesis (SDM) technique. The cell extract of this strain was used for assessing the expression of the recombinant allergen in western blot analysis, and the existence of this protein with a molecular weight of 14.2 kDa was confirmed. To evaluate the efficacy of this strain in the treatment of allergies as an oral vaccine, probiotic ice cream was prepared. After the sensitization of mice, the treatment was performed by oral immunotherapy for 4 weeks, 4 to 5 times per week. 20 μl of functional ice cream with 1012 CFU/ml of r-L. lactis NZ1330 significantly reduced the serum IgE level. The levels of IFN-γ and TGF-β cytokines increased in the 20 μl ice cream treatment group as well as 40 μg/ml pure allergen compared with the PBS-treated group, and IL-4 cytokine levels decreased compared with the PBS-treated group. Overall, 20 μl ice cream with 1012 CFU/ml of the recombinant bacteria resulted in the best performance in terms of improving allergies to Th1 and Treg responses.
format Article
id doaj-art-2df69384381240959a913c5fc199f929
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-2df69384381240959a913c5fc199f9292025-02-03T01:01:55ZengWileyJournal of Immunology Research2314-88612314-71562020-01-01202010.1155/2020/26352302635230Oral Immunotherapy Using Probiotic Ice Cream Containing Recombinant Food-Grade Lactococcus lactis Which Inhibited Allergic Responses in a BALB/c Mouse ModelAlireza Vasiee0Fereshteh Falah1Mojtaba Sankian2Farideh Tabatabaei-Yazdi3Seyed Ali Mortazavi4Department of Food Science and Technology, Faculty of Agriculture, Ferdowsi University of Mashhad, Mashhad, IranDepartment of Food Science and Technology, Faculty of Agriculture, Ferdowsi University of Mashhad, Mashhad, IranImmunology Research Center, Bu-Ali Research Institute, School of Medicine, University of Medical Sciences, Mashhad, IranDepartment of Food Science and Technology, Faculty of Agriculture, Ferdowsi University of Mashhad, Mashhad, IranDepartment of Food Science and Technology, Faculty of Agriculture, Ferdowsi University of Mashhad, Mashhad, IranThis study was conducted to evaluate the effects of recombinant probiotic bacteria as a candidate for oral vaccine with the potential of treating allergy to Amaranthus retroflexus pollens. The main gene of this allergen, Ama r 2, was cloned into the food grade plasmid pNZ7025 and then was electrotransformed into the food grade Lactococcus lactis NZ1330. No expression was observed in the primary structure due to the distance between the ribosome binding site and the start codon. Therefore, the vector structure was corrected using the site-directed mutagenesis (SDM) technique. The cell extract of this strain was used for assessing the expression of the recombinant allergen in western blot analysis, and the existence of this protein with a molecular weight of 14.2 kDa was confirmed. To evaluate the efficacy of this strain in the treatment of allergies as an oral vaccine, probiotic ice cream was prepared. After the sensitization of mice, the treatment was performed by oral immunotherapy for 4 weeks, 4 to 5 times per week. 20 μl of functional ice cream with 1012 CFU/ml of r-L. lactis NZ1330 significantly reduced the serum IgE level. The levels of IFN-γ and TGF-β cytokines increased in the 20 μl ice cream treatment group as well as 40 μg/ml pure allergen compared with the PBS-treated group, and IL-4 cytokine levels decreased compared with the PBS-treated group. Overall, 20 μl ice cream with 1012 CFU/ml of the recombinant bacteria resulted in the best performance in terms of improving allergies to Th1 and Treg responses.http://dx.doi.org/10.1155/2020/2635230
spellingShingle Alireza Vasiee
Fereshteh Falah
Mojtaba Sankian
Farideh Tabatabaei-Yazdi
Seyed Ali Mortazavi
Oral Immunotherapy Using Probiotic Ice Cream Containing Recombinant Food-Grade Lactococcus lactis Which Inhibited Allergic Responses in a BALB/c Mouse Model
Journal of Immunology Research
title Oral Immunotherapy Using Probiotic Ice Cream Containing Recombinant Food-Grade Lactococcus lactis Which Inhibited Allergic Responses in a BALB/c Mouse Model
title_full Oral Immunotherapy Using Probiotic Ice Cream Containing Recombinant Food-Grade Lactococcus lactis Which Inhibited Allergic Responses in a BALB/c Mouse Model
title_fullStr Oral Immunotherapy Using Probiotic Ice Cream Containing Recombinant Food-Grade Lactococcus lactis Which Inhibited Allergic Responses in a BALB/c Mouse Model
title_full_unstemmed Oral Immunotherapy Using Probiotic Ice Cream Containing Recombinant Food-Grade Lactococcus lactis Which Inhibited Allergic Responses in a BALB/c Mouse Model
title_short Oral Immunotherapy Using Probiotic Ice Cream Containing Recombinant Food-Grade Lactococcus lactis Which Inhibited Allergic Responses in a BALB/c Mouse Model
title_sort oral immunotherapy using probiotic ice cream containing recombinant food grade lactococcus lactis which inhibited allergic responses in a balb c mouse model
url http://dx.doi.org/10.1155/2020/2635230
work_keys_str_mv AT alirezavasiee oralimmunotherapyusingprobioticicecreamcontainingrecombinantfoodgradelactococcuslactiswhichinhibitedallergicresponsesinabalbcmousemodel
AT fereshtehfalah oralimmunotherapyusingprobioticicecreamcontainingrecombinantfoodgradelactococcuslactiswhichinhibitedallergicresponsesinabalbcmousemodel
AT mojtabasankian oralimmunotherapyusingprobioticicecreamcontainingrecombinantfoodgradelactococcuslactiswhichinhibitedallergicresponsesinabalbcmousemodel
AT faridehtabatabaeiyazdi oralimmunotherapyusingprobioticicecreamcontainingrecombinantfoodgradelactococcuslactiswhichinhibitedallergicresponsesinabalbcmousemodel
AT seyedalimortazavi oralimmunotherapyusingprobioticicecreamcontainingrecombinantfoodgradelactococcuslactiswhichinhibitedallergicresponsesinabalbcmousemodel